New hope for kids with leukemia in africa: 85% remission goal

NCT ID NCT04794296

Recruiting now Disease control Sponsor: French Africa Pediatric Oncology Group Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 08, 2026 · Updated 30 times

Summary

This study aims to improve treatment for children aged 0-18 with newly diagnosed acute lymphoblastic leukemia (ALL) in low- and middle-income African countries. Researchers will test updated guidelines that include stronger chemotherapy for high-risk cases. The main goal is to achieve complete remission in about 85% of children after the first phase of treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHILDHOOD ALL are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

CHU Donka 030 BP 554
RECRUITING

Conakry, Guinea

Contact Phone: •••-•••-•••• Email: •••••@•••••
CHU de Treichville à ABIDJAN
RECRUITING

Abidjan, Côte d’Ivoire

Contact Email: •••••@•••••
Hôpital Aristide Le Dantec, Avenue Pasteur,
RECRUITING

Dakar, BP 3001, Senegal

Contact Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

CHILDHOOD ALL